Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Flcntm1.1Lss mutation
(0 available);
any
Flcn mutation
(40 available)
Flcntm1Baba mutation
(0 available);
any
Flcn mutation
(40 available)
Tg(CAG-cre/Esr1*)1Lbe mutation
(0 available)
|
|
|
immune system
|
• pro-B cell block in the bone marrow following tamoxifen-treatment
|
|
• CD19+ cells in the spleen following tamoxifen-treatment
|
renal/urinary system
|
• in tamoxifen-treated mice
• in tamoxifen-treated mice however, kidney phenotype is rescued by rapamycin treatment
|
|
• in tamoxifen-treated mice
• however, kidney phenotype is rescued by rapamycin treatment
|
hematopoietic system
|
• pro-B cell block in the bone marrow following tamoxifen-treatment
|
|
• CD19+ cells in the spleen following tamoxifen-treatment
|
growth/size/body
|
• in tamoxifen-treated mice
• in tamoxifen-treated mice however, kidney phenotype is rescued by rapamycin treatment
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Flcntm1.1Lss mutation
(0 available);
any
Flcn mutation
(40 available)
Flcntm1Baba mutation
(0 available);
any
Flcn mutation
(40 available)
Tg(Cdh16-cre)91Igr mutation
(1 available)
|
|
|
mortality/aging
|
• treatment of mice with rapamycin extends lifespan nearly 2-fold, but all animals die of renal failure
|
|
• animals appear normal at birth, but develop distended abdomens and die around 3 weeks of age from renal failure
|
growth/size/body
|
• at 3 weeks, kidneys are markedly cystic
|
|
• by 2 weeks, mice display distended abdomens which are very pronounced at time of death
|
|
• at time of death, enlarged kidneys fill abdominal cavity; penetrance of phenotype is 100%
• enlargement begins at 1 week due to collecting duct dilation
|
|
• between P7 and P21, kidney to body weight ratio (under wet and dried conditions) dramatically increases relative to littermate controls
|
renal/urinary system
|
• kidneys have fine reticular pattern of interstitial tissue containing numerous blood vessels, not observed in control kidneys
|
|
• in culture, tubule cells show much higher proliferation rate than control cells
|
|
• at 3 weeks, kidneys are markedly cystic
|
|
• at time of death, enlarged kidneys fill abdominal cavity; penetrance of phenotype is 100%
• enlargement begins at 1 week due to collecting duct dilation
|
|
• between P7 and P21, kidney to body weight ratio (under wet and dried conditions) dramatically increases relative to littermate controls
|
|
• by 2 weeks, lumens of ducts are cystic
• at 3 weeks, collecting ducts in the medulla and extending into the papilla are severely cystic
|
|
• by 1 week of age, dilation of collecting ducts is observed
|
|
• anatomical distinction between cortex and medulla is disrupted
|
|
• regions of pyramidal infarctions are observed at 3 weeks
|
|
• by 2 weeks, lumens of tubules are cystic
• most cells lining the tubules are hypertrophic with enlarged nuclei and cytoplasm; many cells ar hyperplastic
|
|
• by 2 weeks, lumens of tubules are cystic
|
|
• occurs around 3 weeks of age
|
cardiovascular system
|
• kidneys have fine reticular pattern of interstitial tissue containing numerous blood vessels, not observed in control kidneys
|
homeostasis/metabolism
cellular
|
• in culture, tubule cells show much higher proliferation rate than control cells
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Flcntm1Baba mutation
(0 available);
any
Flcn mutation
(40 available)
Fnip1tm1.1Baba mutation
(0 available);
any
Fnip1 mutation
(59 available)
Fnip2tm1.1Lss mutation
(0 available);
any
Fnip2 mutation
(60 available)
Tg(Cdh16-cre)91Igr mutation
(1 available)
|
|
|
renal/urinary system
|
• no increase in severity of cystic phenotype compared to mutant mice wild-type for Flcn
|
|
• no increase in severity of phenotype compared to mutant mice wild-type for Flcn
|
growth/size/body
|
• no increase in severity of cystic phenotype compared to mutant mice wild-type for Flcn
|
|
• no increase in severity of phenotype compared to mutant mice wild-type for Flcn
|